On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
Risk of hepatocellular carcinoma (HCC) occurrence or recurrence following direct-acting antiviral (DAA) HCV therapy remains unclear. This study however concludes there is no evidence to support withholding DAA therapy in patients with HCV-related cirrhosis or after curative HCC management.
US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations
US opioid overdose death rates have increased between 2000 and 2014. This study documents the differences in trends in prescription opioid overdose-related (POD) and heroin overdose related (HOD) hospitalizations.
If Heroin Assisted Treatment Works, Why Isn't Australia Providing It To Those In Need?
"Do we really have a right to deny the evidence and refuse to provide a proven treatment that will help those in need?"
Does exposure to opioid substitution treatment in prison reduce the risk of death after release?
People with opioid use disorder (OUD) in prison face an acute risk of death after release. We estimated whether prison-based opioid substitution treatment (OST) reduces this risk.
Women's drug deaths soaring across England and Wales as their needs are overlooked
Women’s deaths as a result of drug misuse have increased by a staggering 82 per cent in England and Wales over the last decade.
Criminalising drug users linked to increased HIV levels
A ground-breaking review provides stark evidence of the damage criminalisation has on preventing and treating HIV among people who inject drugs.
Language matters
The use of inappropriate language and words can be a barrier to access to medicines for the legitimate use of opioids, such as treatment of pain and opioid dependence.
Hepatitis C ‘giant’ still growing
In 1993 what was at the time Britain’s magazine for the drug misuse sector alerted readers to an invisible “sleeping giant” – hepatitis C.
Fentanyl in the US heroin supply: A rapidly changing risk environment
The supply of heroin into the US has changed with new source forms and market strategies. Of particular concern is the rampant and persistent adulteration of heroin with synthetic opioids, most conspicuously the family of fentanyls.
How to Win a War on Drugs
Portugal treats addiction as a disease, not a crime. Op-Ed Columnist, NY Times
Share this on: